eHealth Utdelningar och återköp
Utdelning kriterier kontrolleras 0/6
eHealth har inte registrerat sig för att betala utdelning.
Viktig information
n/a
Avkastning på utdelning
3.3%
Återköpsavkastning
| Total avkastning till aktieägarna | 3.3% |
| Framtida utdelningsavkastning | 0% |
| Utdelningstillväxt | n/a |
| Nästa utbetalningsdag för utdelning | n/a |
| Ex utdelningsdag | n/a |
| Utdelning per aktie | n/a |
| Utdelningsandel | n/a |
Senaste utdelnings- och återköpsuppdateringar
Inga uppdateringar
Recent updates
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.
EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin Repair
Analysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused Turnaround
Analysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused Turnaround
Analysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.EHTH: Higher 2025 Earnings Guidance Will Support Future Performance
Analysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower
Feb 10
EHTH: Enrollment Strength And Softer Competition Will Support Future Performance
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.EHTH: Solid Enrollment Trends And Easing Competition Will Support Future Margins
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin Expansion
Analysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion Potential
Analysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce
Dec 19EHTH: Improving Enrollment Dynamics Will Support Future Upside Potential
Analysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.EHTH: Future Enrollment Trends Will Support Further Upside Potential
Narrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.EHTH: Future Profit Margins Will Drive Upside Despite Consumer Confusion
Analysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat
Nov 08eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%
Oct 28eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Sep 03The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues
May 15
Medicare Focus And AI Projects Will Improve Operations
Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet
Mar 16eHealth: Another Big Run, Lock In, And Run House Money
Feb 26Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost
Dec 23Bull Run For EHealth, Inc.: Stock Flying On Solid Enrollment
Dec 17A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb
Nov 08Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump
Aug 30We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation
Jun 06Stabilitet och tillväxt i betalningar
Hämta utdelningsdata
Stabil utdelning: Otillräcklig data för att avgöra om EHTH s utdelningar per aktie har varit stabila tidigare.
Växande utdelning: Otillräcklig data för att avgöra om EHTH s utdelningsbetalningar har ökat.
Utdelningsavkastning jämfört med marknaden
| eHealth Utdelningsavkastning jämfört med marknaden |
|---|
| Segment | Utdelningsavkastning |
|---|---|
| Företag (EHTH) | n/a |
| Marknadens lägsta 25% (US) | 1.4% |
| Marknad Topp 25% (US) | 4.2% |
| Genomsnitt för branschen (Insurance) | 2.6% |
| Prognosanalytiker (EHTH) (upp till 3 år) | 0% |
Anmärkningsvärd utdelning: Det går inte att utvärdera EHTH s utdelningsavkastning mot de lägsta 25 % av utdelningsbetalarna, eftersom företaget inte har rapporterat några senaste utbetalningar.
Hög utdelning: Det går inte att utvärdera EHTH s utdelningsavkastning mot de översta 25 % av utdelningsbetalarna, eftersom företaget inte har rapporterat några senaste utbetalningar.
Vinstutdelning till aktieägarna
Resultattäckning: Otillräcklig data för att beräkna EHTH s utbetalningskvot för att avgöra om dess utdelningar täcks av intäkter.
Kontantutbetalning till aktieägarna
Kassaflödestäckning: Det går inte att beräkna hållbarheten för utdelningar eftersom EHTH inte har rapporterat några utbetalningar.
Upptäck bolag med stark utdelning
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/04/30 23:54 |
| Aktiekurs vid dagens slut | 2026/04/30 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
eHealth, Inc. bevakas av 25 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Nathaniel Schindler | BofA Global Research |